<DOC>
	<DOCNO>NCT00002576</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Randomized phase III trial compare effectiveness combination chemotherapy consist cyclophosphamide , vincristine , prednisolone , either mitoxantrone doxorubicin treat patient intermediate- high-grade non-Hodgkin 's lymphoma .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Older Patients With Intermediate- High-Grade Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : I. Assess treatment-related neurologic hematologic toxicity patient age 65 year intermediate- high-grade non-Hodgkin 's lymphoma randomize CHOP ( cyclophosphamide , doxorubicin , vincristine , prednisolone ) vs. MCOP ( mitoxantrone , cyclophosphamide , vincristine , prednisolone ) . II . Compare survival rate patient . OUTLINE : Randomized study . The following acronym use : CHOP CTX/DOX/VCR/PRDL CTX Cyclophosphamide , NSC-26271 DHAD Mitoxantrone , NSC-301739 DOX Doxorubicin , NSC-123127 MCOP DHAD/CTX/VCR/PRDL PRDL Prednisolone , NSC-9900 VCR Vincristine , NSC-67574 Arm I : 4-Drug Combination Chemotherapy . CHOP . Arm II : 4-Drug Combination Chemotherapy . MCOP . PROJECTED ACCRUAL : A total 200 patient enter approximately 5 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm intermediate highgrade non Hodgkin 's lymphoma follow type : Diffuse centroblastic Diffuse immunoblastic B Tcell lymphoblastic Peripheral Tcell ( mixed large cell ) Ki1 No Stage IA ( nonbulky ) disease suitable radiotherapy alone PATIENT CHARACTERISTICS : Age : 65 Performance status : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No severe ischemic heart disease No cardiomyopathy would restrict doxorubicin use Other : No serious medical condition would affect treatment outcome No prior malignancy except : Nonmelanomatous skin cancer Adequately treat situ cervical cancer Sufficiently fit receive treatment PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage I adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage I adult diffuse large cell lymphoma</keyword>
	<keyword>stage I adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage I adult lymphoblastic lymphoma</keyword>
	<keyword>stage I adult Burkitt lymphoma</keyword>
	<keyword>stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage II adult diffuse large cell lymphoma</keyword>
	<keyword>stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage II adult lymphoblastic lymphoma</keyword>
	<keyword>stage II adult Burkitt lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult lymphoblastic lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>contiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>contiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>contiguous stage II adult lymphoblastic lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>noncontiguous stage II adult lymphoblastic lymphoma</keyword>
</DOC>